Literature DB >> 11138780

Transcriptional regulation of RANTES expression in T lymphocytes.

A Song1, T Nikolcheva, A M Krensky.   

Abstract

We first identified the RANTES chemokine as part of a search for genes expressed by T lymphocytes "late", 3-5 days, after T-cell activation. The kinetics of expression of RANTES and a small number of other genes are unusual and the mechanism of such delayed expression is unknown. In order to uncover a mechanism for such "late" expression, we identified and characterized the RANTES promoter and a novel transcription factor regulating RANTES expression in T lymphocytes. RANTES factor of late activated T lymphocytes (RFLAT)-1 is a member of the Krüppel-like family of transcription factors. Like RANTES, RFLAT-1 expression is "late" after T-cell activation. But, unlike RANTES, regulation of RFLAT-1 expression appears to be translational rather than transcriptional.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138780     DOI: 10.1034/j.1600-065x.2000.17610.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  33 in total

Review 1.  Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.

Authors:  R Böhmová; O Viklický
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 3.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

4.  Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.

Authors:  Paula A Lanthier; Gail E Huston; Amy Moquin; Sheri M Eaton; Frank M Szaba; Lawrence W Kummer; Micheal P Tighe; Jacob E Kohlmeier; Patrick J Blair; Michael Broderick; Stephen T Smiley; Laura Haynes
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

5.  Unified translation repression mechanism for microRNAs and upstream AUGs.

Authors:  Subramanian S Ajay; Brian D Athey; Inhan Lee
Journal:  BMC Genomics       Date:  2010-03-05       Impact factor: 3.969

6.  Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock.

Authors:  Jolana Lipkova; Jiri Parenica; Kamil Duris; Katerina Helanova; Josef Tomandl; Lenka Kubkova; Anna Vasku; Monika Goldbergova Pavkova
Journal:  Clin Exp Med       Date:  2014-06-17       Impact factor: 3.984

7.  Tributyltin exposure alters cytokine levels in mouse serum.

Authors:  Shanieek Lawrence; Samuel T Pellom; Anil Shanker; Margaret M Whalen
Journal:  J Immunotoxicol       Date:  2016-09-07       Impact factor: 3.000

8.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

9.  Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial.

Authors:  Mitsukuni Suenaga; Sebastian Stintzing; Shu Cao; Wu Zhang; Dongyun Yang; Yan Ning; Satoshi Okazaki; Martin D Berger; Yuji Miyamoto; Marta Schirripa; Shivani Soni; Afsaneh Barzi; Volker Heinemann; Heinz-Josef Lenz
Journal:  Eur J Cancer       Date:  2018-12-14       Impact factor: 9.162

Review 10.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.